Airway granulation response to lung-implantable medical devices: a concise overview
- PMID: 34348981
- PMCID: PMC9488845
- DOI: 10.1183/16000617.0066-2021
Airway granulation response to lung-implantable medical devices: a concise overview
Abstract
Increasing numbers of endoscopically implantable devices are implanted in the airways, such as airway stents, one-way valves and coils, to treat both malignant and benign diseases. They significantly improve patient outcomes, but their long-term effectiveness and sustainability is hampered by the reaction of the formation of granulation tissue. Factors including procedural-related tissue injury; micro-organism presence; device-related factors, such as the material, design and sizing in relation to the airway; and patient-related factors, including genetic susceptibility, comorbidities and medication use, might all effect the severity of the tissue response and the subsequent degree of granulation tissue formation. However, research into the underlying mechanism and risk factors is scarce and therefore our knowledge is limited. Joint efforts from the scientific community, both pre-clinical and clinical, are needed to gain a deeper understanding and eventually improve the long-term treatment effectiveness of lung-implantable devices.
Copyright ©The authors 2021.
Conflict of interest statement
Conflict of interest: S.A. Roodenburg has nothing to disclose. Conflict of interest: S.D. Pouwels has nothing to disclose. Conflict of interest: D-J. Slebos reports grants or contracts, consulting fees, honoraria and travel expenses from PulmonX Corp USA; and grants or contracts, honoraria and travel expenses from PneumRX/BTG USA, outside the submitted works.
Figures
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources